Delta Lloyd’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.54M | Hold |
16,975
| – | – | 0.04% | 314 |
|
|
2017
Q1 | $1.49M | Hold |
16,975
| – | – | 0.04% | 306 |
|
|
2016
Q4 | $1.41M | Buy |
16,975
+5,698
| +51% | +$472K | 0.04% | 305 |
|
|
2016
Q3 | $1.04M | Hold |
11,277
| – | – | 0.03% | 388 |
|
|
2016
Q2 | $877K | Hold |
11,277
| – | – | 0.03% | 412 |
|
|
2016
Q1 | $930K | Hold |
11,277
| – | – | 0.03% | 388 |
|
|
2015
Q4 | $1.18M | Buy |
11,277
+340
| +3% | +$35.6K | 0.04% | 315 |
|
|
2015
Q3 | $1.15M | Hold |
10,937
| – | – | 0.04% | 316 |
|
|
2015
Q2 | $1.5M | Buy |
10,937
+3,679
| +51% | +$503K | 0.05% | 276 |
|
|
2015
Q1 | $904K | Buy |
7,258
+1,467
| +25% | +$183K | 0.03% | 319 |
|
|
2014
Q4 | $524K | Hold |
5,791
| – | – | 0.02% | 432 |
|
|
2014
Q3 | $418K | Hold |
5,791
| – | – | ﹤0.01% | 476 |
|
|
2014
Q2 | $360K | Hold |
5,791
| – | – | 0.01% | 491 |
|
|
2014
Q1 | $395K | Buy |
5,791
+1,664
| +40% | +$114K | 0.01% | 424 |
|
|
2013
Q4 | $290K | Sell |
4,127
-82,000
| -95% | -$5.76M | 0.01% | 486 |
|
|
2013
Q3 | $6.22M | Sell |
86,127
-33,129
| -28% | -$2.39M | 0.24% | 95 |
|
|
2013
Q2 | $6.65M | Buy |
+119,256
| New | +$6.65M | 0.26% | 89 |
|